The legal cannabis industry is budding in North America. Yeah, it may sound cliche, but there's really no better way to describe the rapid growth in legal weed sales. According to cannabis research firm ArcView, legal pot revenue grew by 33% in 2017 to $9.7 billion in North America, and it's expected to near $25 billion by 2021, representing a compound annual growth rate of a scorching 28%.
Where's this growth coming from? First of all, Canada legalized medical marijuana back in 2001 and now stands on the verge of allowing adults to purchase recreational weed, legally. Waving the proverbial green flag on adult-use marijuana is a $5 billion bump to the legal weed industry in Canada. To our south, Mexico legalized medical cannabis in June of 2017. And domestically, 29 states have passed broad-based medical pot laws since 1996, with nine states giving the OK for recreational weed use.
Image source: Getty Images.
Top 5 Medical Stocks For 2019: Cherry Hill Mortgage Investment Corporation(CHMI)
Advisors' Opinion:- [By Ethan Ryder]
Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cherry Hill Mortgage Investment Corp (NYSE:CHMI) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 152,335 shares of the real estate investment trust’s stock, valued at approximately $2,721,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.98% of Cherry Hill Mortgage Investment as of its most recent filing with the SEC.
- [By Stephan Byrd]
Welltower (NYSE: WELL) and Cherry Hill Mortgage Investment (NYSE:CHMI) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.
- [By Lisa Levin]
Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial. scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review. Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd. Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results. Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday. Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results. Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results. Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91. Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results. Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance. Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results. Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday. Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq. Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent - [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial. CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment. Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores. Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday. Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance. Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design. Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter. Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering. Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million. Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday. Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2
Top 5 Medical Stocks For 2019: ArQule Inc.(ARQL)
Advisors' Opinion:- [By Stephan Byrd]
ArQule, Inc. (NASDAQ:ARQL) Director Ronald M. Lindsay acquired 23,900 shares of the company’s stock in a transaction on Thursday, May 10th. The stock was acquired at an average price of $2.67 per share, for a total transaction of $63,813.00. Following the purchase, the director now directly owns 43,900 shares of the company’s stock, valued at $117,213. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on ArQule (ARQL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin] Gainers Foot Locker, Inc. (NYSE: FL) rose 15.3 percent to $53.50 in pre-market trading after the company reported better-than-expected results for its first quarter. Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 10.4 percent to $4.58 in pre-market trading. Evofem Biosciences reported closing of public offering of common stock and warrants. Resonant Inc. (NASDAQ: RESN) rose 7.3 percent to $4.88 in pre-market trading after declining 1.94 percent on Thursday. SolarEdge Technologies, Inc. (NASDAQ: SEDG) shares rose 5.7 percent to $59.65 in pre-market trading after falling 8.43 percent on Thursday. Yirendai Ltd. (NYSE: YRD) rose 5 percent to $30.00 in pre-market trading after reporting Q1 results. Deckers Outdoor Corp (NYSE: DECK) rose 4.9 percent to $108.75 in pre-market trading after reporteingd better-than-expected results for its fiscal fourth quarter. Blue Apron Holdings, Inc. (NYSE: APRN) rose 4.2 percent to $3.21 in pre-market trading after gaining 3.70 percent on Thursday. Recro Pharma, Inc. (NASDAQ: REPH) rose 4 percent to $5.85 in pre-market trading after dropping 54.67 percent on Thursday. ArQule, Inc. (NASDAQ: ARQL) rose 3.8 percent to $4.70 in pre-market trading after gaining 4.86 percent on Thursday. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) shares rose 2.9 percent to $2.85 in pre-market trading after climbing 7.78 percent on Thursday. Bilibili Inc. (NASDAQ: BILI) shares rose 2.5 percent to $14.20 in pre-market trading after surging 11.33 percent on Thursday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Top 5 Medical Stocks For 2019: National Presto Industries, Inc.(NPK)
Advisors' Opinion:- [By Joseph Griffin]
OppenheimerFunds Inc. cut its stake in shares of National Presto Industries Inc. (NYSE:NPK) by 62.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,899 shares of the conglomerate’s stock after selling 3,188 shares during the quarter. OppenheimerFunds Inc.’s holdings in National Presto Industries were worth $235,000 as of its most recent SEC filing.
Top 5 Medical Stocks For 2019: Cray Inc(CRAY)
Advisors' Opinion:- [By Ethan Ryder]
Cray (NASDAQ: CRAY) and One Stop Systems (NASDAQ:OSS) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, dividends, earnings and profitability.
- [By Motley Fool Staff]
Gardner: There's a lot of biotech and some computer companies. We once visited the Cray Corporation (NASDAQ:CRAY), which was one of the early supercomputer companies. Seymour Cray was one of the pioneers of supercomputing. If you look up Cray Computers, they were the supercomputers back in the 80s, when computers were a lot bigger than they are today, and probably slower, but they were super back then. Anyway, that was a Minneapolis company I once visited. Our dad used to take us, occasionally, on trips. We'd just drop by corporate headquarters and talk to an investor relations person. That was one of the times I did that. It wasn't like I did it dozens of times. We did maybe five or six times. But I'll always remember Cray Computer.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Cray (CRAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Fmr LLC boosted its position in Cray Inc. (NASDAQ:CRAY) by 1.0% in the 2nd quarter, Holdings Channel reports. The firm owned 789,269 shares of the technology company’s stock after acquiring an additional 7,860 shares during the quarter. Fmr LLC’s holdings in Cray were worth $19,416,000 at the end of the most recent reporting period.
Top 5 Medical Stocks For 2019: Callon Petroleum Company(CPE)
Advisors' Opinion:- [By Lee Jackson]
This is one of the small cap stocks that the Jefferies team feels comfortable about currently. Callon Petroleum Company (NYSE: CPE) is an independent oil and natural gas company. The Company is engaged in the exploration, development, acquisition and production of oil and natural gas properties. The Company focuses on the acquisition and development of unconventional oil and natural gas reserves in the Permian Basin.
- [By Joseph Griffin]
Here are some of the media headlines that may have effected Accern’s analysis:
Get Callon Petroleum alerts: Callon Petroleum (CPE) Expected to Post Earnings of $0.22 Per Share (americanbankingnews.com) Callon Petroleum (CPE) Given Consensus Recommendation of “Buy” by Brokerages (americanbankingnews.com) Basic Materials Stock Recap: Callon Petroleum Company (CPE) (stockdigest.info) Head-To-Head Analysis: Callon Petroleum (CPE) vs. CNOOC (CEO) (americanbankingnews.com) Callon Petroleum (CPE) Short Interest Update (americanbankingnews.com)CPE has been the subject of a number of recent research reports. ValuEngine lowered Callon Petroleum from a “hold” rating to a “sell” rating in a report on Wednesday, March 7th. B. Riley set a $12.00 target price on Callon Petroleum and gave the company a “hold” rating in a report on Friday, March 9th. Piper Jaffray Companies reiterated a “buy” rating and issued a $16.00 target price on shares of Callon Petroleum in a report on Thursday, March 15th. Jefferies Financial Group set a $18.00 target price on Callon Petroleum and gave the company a “buy” rating in a report on Wednesday, March 14th. Finally, Stifel Nicolaus set a $20.00 target price on Callon Petroleum and gave the company a “buy” rating in a report on Wednesday, March 28th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $15.88.
- [By Shane Hupp]
Shares of Callon Petroleum (NYSE:CPE) traded down 5% during mid-day trading on Thursday . The stock traded as low as $12.47 and last traded at $12.48. 6,420,719 shares traded hands during mid-day trading, an increase of 45% from the average session volume of 4,431,217 shares. The stock had previously closed at $13.14.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers Zoe's Kitchen, Inc. (NYSE: ZOES) fell 27.8 percent to $10.45 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company also lowered its FY18 sales outlook from $358million-$368 million to $345 million-$352 million. Hibbett Sports, Inc. (NASDAQ: HIBB) shares fell 15.6 percent to $24.50 in pre-market trading after the company reported weaker-than-expected results for its first quarter. Rockwell Medical, Inc. (NASDAQ: RMTI) fell 15.5 percent to $5.02 in the pre-market trading session after the company disclosed that its President and CEO Robert Chioini was terminated. BG Staffing Inc (NYSE: BGSF) shares fell 12.7 percent to $19.00 in pre-market trading after reporting a common stock offering. 8x8, Inc. (NASDAQ: EGHT) fell 9.3 percent to $20.00 in pre-market trading after reporting downbeat quarterly earnings. Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) fell 7.7 percent to $2.35 in pre-market trading after rising 3.88 percent on Thursday. Gap, Inc. (NYSE: GPS) shares fell 7.5 percent to $30.49 in pre-market trading after the company posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter. California Resources Corporation (NYSE: CRC) fell 6.4 percent to $33.91 in pre-market trading. Buckle Inc (NYSE: BKE) fell 4.9 percent to $24.50 in pre-market trading following weak quarterly sales. China Rapid Finance Limited (NYSE: XRF) shares fell 4.9 percent to $3.13 in pre-market trading after climbing 11.53 percent on Thursday. Ross Stores, Inc. (NASDAQ: ROST) fell 4.8 percent to $78.98 in pre-market trading. Ross Stores reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter. Callon Petroleum Company (NYSE: CPE) shares fell 4.7 percent to $11.90 in pre-market trading after the company reported pricing of common - [By Stephan Byrd]
Sundance Energy Australia (OTCMKTS: SDCJF) and Callon Petroleum (NYSE:CPE) are both oils/energy companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Callon Petroleum (CPE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment